For patients with cancer and chronic constipation, elobixibat was shown to be safe and effective during an observational study, the results of which were published in The Oncologist. Chronic constipation affects up to 87% of patients with cancer receiving palliative care and has been associated with reduced quality of life and extreme discomfort. To address…
For five of six actinic damage and skin cancer index stages, consensus-based recommendations developed
SBRT was compared with external beam radiotherapy to determine which provided better pain control for patients with spinal metastases.
An analysis of studies showed that use of an angiotensin-converting enzyme inhibitor prevented cardiotoxicity in patients with cancer receiving an anthracycline.
Sepsis and septic shock are common oncologic emergencies that require vigilant, timely diagnosis and intervention. Timely and effective detection and treatment of these conditions are key to patient survival.
A phase 3 clinical trial determined if adding aprepitant to antiemetic prophylaxis would further reduce the risks of chemotherapy-induced nausea and vomiting for women receiving chemotherapy for GI cancer.
A review of the factors that contribute to the occurrence of extravasation in patients receiving IV treatments is presented with management steps.
Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.
In this prospective study, researchers sought to determine the effect of mean muscle mass on clinical outcomes and survival among hospitalized patients with advanced cancer.
A randomized trial sought to determine the effectiveness of electroacupuncture and auricular acupuncture in managing musculoskeletal pain in cancer survivors.
